ArticlePloS one2025
Depression and anxiety mediate the relationship between COVID-19 stay-at-home orders and tobacco and marijuana use.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe COVID-19 pandemic had notable impacts on the mental health of the U.S. population. There were concerns about how the pandemic affected substance use in the population. The overall objective of this study was to assess whether COVID-19 Stay-At-Home (SAH) orders, an ambient ecological stressor, as well as the severity of depressive and anxious symptoms, can explain tobacco and marijuana use.
methodsData come from the first seven waves of the Understanding America Study, a nationally representative longitudinal web-based panel study. A total of 7,554 persons participated in the first seven waves, resulting in 43,582 observations. Cigarette use as a measure was not included until wave four of the study; 7,034 persons participated in waves four through seven, resulting in 24,893 observations. The primary outcomes were self-reported past seven-day use of cigarette products and past seven-day use of marijuana products. Self-reported depressive and anxious symptom severity, the proposed mediator, was measured using the Patient Health Questionnaire-4 (PHQ-4). The primary exposure was a binary indicator for the presence of an SAH order. All variables were measured biweekly. Generalized Estimating Equations (GEE) were used to assess single-mediator models.
resultsPersons under SAH orders had 2.18 (95% CI: 1.27, 3.73) times the odds of moderate-to-severe depression across the first seven waves, relative to those living in states without SAH orders. Those with moderate-to-severe depression and anxiety had lower odds of both marijuana (OR = 0.37, 95% CI: 0.17, 0.84) and cigarette use (OR = 0.29, 95% CI: 0.13, 0.65) compared to those with normal-mild PHQ-4 scores. Worsened mental health within a person resulted in 0.22 (95% CI: 0.12, 0.40) times the odds of marijuana use and 0.26 (95% CI: 0.15, 0.47) times the odds of cigarette use. Tests of the joint effects suggest evidence of multiple mediated pathways.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.